stella
beta
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma — Stella
Home
/
Metastatic Uveal Melanoma
/
View on ClinicalTrials.gov
Recruiting
Back to Metastatic Uveal Melanoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(33 sites)
United States
HonorHealth Research Insisute, Scottsdale, Arizona
UC San Diego Moores Cancer Center, La Jolla, California
The Angeles Clinic and Research Institute, Los Angeles, California
University of California Los Angeles, Los Angeles, California
Stanford Cancer Institute, Palo Alto, California
University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora, Colorado
The Melanoma & Skin Cancer Institute, Englewood, Colorado
Georgetown University Medical Center, Washington D.C., District of Columbia
Mayo Clinic - Jacksonville FL, Jacksonville, Florida
Sylvester Comprehensive Cancer Center, Miami, Florida
Emory Winship Cancer Institute, Atlanta, Georgia
Northwestern Memorial Hospital, Chicago, Illinois
University of Chicago Medical Center, Chicago, Illinois
University of Iowa, Iowa City, Iowa
Massachusetts General Hospital, Boston, Massachusetts
Mayo Clinic Rochester, Rochester, Minnesota
Memorial Sloan Kettering Cancer Center, New York, New York
Duke University Medical Center, Durham, North Carolina
The Ohio State University, Columbus, Ohio
Thomas Jefferson University, Philadelphia, Pennsylvania
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee
University of Tennessee Medical Center, Knoxville, Tennessee
Sarah Cannon Research Institute, Nashville, Tennessee
Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville, Tennessee
UT Southwestern Medical Center, Dallas, Texas
The University Of Texas Md Anderson Cancer Center, Houston, Texas
Fred Hutchinson Cancer Center, Seattle, Washington
University Of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Australia
Melanoma Institute Australia, Wollstonecraft, New South Wales
Peter MacCallum Cancer Centre, Melbourne, Victoria
United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Merseyside
The Royal Marsden NHS Foundation Trust, London